Want to join the conversation?
$AMGN and $ARWR announced two agreements to develop and commercialize RNA interference (RNAi) therapies for cardiovascular disease. Under one agreement, $AMGN receives a worldwide, exclusive license to $ARWR's RNAi ARC-LPA program. These RNAi molecules are designed to reduce elevated lipoprotein, which is a risk factor for cardiovascular disease.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!